is a sexually transmitted organism with high levels of resistance to the recommended first-line therapy, azithromycin. The ResistancePlus MG test concurrently detects and the presence of macrolide-resistance mutations (MRM). European, UK and Australian guidelines recommend a diagnostic test that reports MRM to optimize treatment through resistance-guided therapy. Hence, for samples collected for use on other platforms, reflex testing using the ResistancePlus MG test would be beneficial.

To validate the ResistancePlus MG assay using samples collected in Aptima buffer for testing on the Hologic Panther.

Positive (=99) and negative (=229) clinical samples collected in Aptima buffer were extracted on the MagNA Pure 96 (Roche Diagnostics), and tested with the ResistancePlus MG test on the LightCycler 480 II (Roche Diagnostics). Results were compared to matched samples collected using standard sample collection (urine or swab resuspended in PBS), with positive percent agreement (PPA), negative percent agreement (NPA) and Cohen’s Kappa statistic.

The ResistancePlus MG test had high performance with a 200 µl input volume (PPA/NPA for detection, 92.9 % [95 % confidence interval (CI): 85.5–96.9]/100 % [95 % CI: 97.9–100], MRM detection, 96.9 % [95 % CI: 88.2–99.5]/85.7 % [95 % CI: 66.4–95.3]) and for 1 ml input volume (PPA/NPA for M. genitalium detection, 95.9%/96.6%, MRM detection, 98.4%/90.3%). Samples remained positive after storage at room temperature beyond the manufacturer-recommended storage of <60 days (mean storage time for 1 ml extraction: 129 days).

Samples collected using Aptima collection kits are suitable for reflex testing using the ResistancePlus MG test, allowing detection of macrolide resistance.

This study was supported by the:
  • Gerald Murray , Department of Health, State Government of Victoria
  • Gerald Murray , Department of Industry and Science, Australian Government , (Award ICG000220)
  • Deborah A. Williamson , National Health and Medical Research Council , (Award GNT1123854)
  • Tim R. H. Read , National Health and Medical Research Council , (Award 1091536)

Article metrics loading...

Loading full text...

Full text loading...



  1. Walker J, Fairley CK, Bradshaw CS, Tabrizi SN, Twin J et al. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. Clin Infect Dis 2013; 56:1094–1100 [CrossRef]
    [Google Scholar]
  2. Bradshaw CS, Jensen JS, Waites KB. New horizons in Mycoplasma genitalium treatment. J Infect Dis 2017; 216:S412–S419 [CrossRef]
    [Google Scholar]
  3. Machalek DA, Tao Y, Shilling H, Jensen JS, Unemo M et al. P601 Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium: a systematic review and meta-analysis. Sex Transm Infect 2019; 95:
    [Google Scholar]
  4. Durukan D, Read TRH, Murray G, Doyle M, Chow EPF et al. Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability. J Clin Microbiol 2019; Accepted for publication: [CrossRef]
    [Google Scholar]
  5. Read TRH, Fairley CK, Murray GL, Jensen JS, Danielewski J et al. Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation. Clin Infect Dis 2019; 68:554–560 [CrossRef]
    [Google Scholar]
  6. Li Y, Su X, Le W, Li S, Yang Z et al. Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance. Clin Infect Dis 2019pii: ciz294
    [Google Scholar]
  7. Tabrizi SN, Costa AM, Su J, Lowe P, Bradshaw CS et al. Evaluation of the Hologic Panther transcription-mediated amplification assay for detection of Mycoplasma genitalium: table 1. J Clin Microbiol 2016; 54:2201–2203 [CrossRef]
    [Google Scholar]
  8. Tabrizi SN, Tan LY, Walker S, Twin J, Poljak M et al. Multiplex assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance using PlexZyme and PlexPrime technology. PLoS One 2016; 11:e0156740 [CrossRef]
    [Google Scholar]
  9. Update to the 2015 BASHH UK national guideline on the management of non-gonococcal urethritis 2018 [9th August 2019]. Available from. https://www.bashh.org/guidelines
  10. Australian STI Management Guidelines For Use in Primary Care 2018 [9th August 2019]. Available from. http://www.sti.guidelines.org.au/sexually-transmissible-infections/mycoplasma-genitalium
  11. Horner PJ, Blee K, Falk L, van der Meijden W, Moi H. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS 2016; 27:928–937 [CrossRef]
    [Google Scholar]
  12. Murray GL, Danielewski J, Bodiyabadu K, Machalek DA, Bradshaw CS et al. Analysis of infection loads in Mycoplasma genitalium clinical specimens using a commercial diagnostic test. J Clin Microbiol 2019; 57:e00344–19 [CrossRef]
    [Google Scholar]
  13. Twin J, Jensen JS, Bradshaw CS, Garland SM, Fairley CK et al. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS One 2012; 7:e35593 [CrossRef]
    [Google Scholar]
  14. Murray GL, Su JP, Birnie J, Danielewski J, Machalek DA et al. The impact of sample storage on molecular‐based detection of Mycoplasma genitalium . J Appl Microbiol 2019; 127:1219–1223 [CrossRef]
    [Google Scholar]
  15. Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol 2016; 30:1650–1656 [CrossRef]
    [Google Scholar]

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error